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NEWS
Important Information About OnCore Clinical Trail Management System
Implementation at UMMS
On October 24th, 2016, the medical school community received information about the implementation of
OnCore Clinical Trial Management System at the University of Massachusetts Medical School.
 
Please see the attached fact sheet from the CTMS implementation leadership team with additional
information about implementation, including project entry guidelines, account requests and calendar build
services.  We will continue to provide updates to the Medical School community about the OnCore
implementation on an ongoing basis.
Read More
DID YOU KNOW?
Pitching to the Media
Sally Gore, MS MS LIS
Research Evaluation Analyst, UMCCTS
Note: This month's column features guest authors, Jennifer Rosinksi, UMMS Commonwealth Medicine,
and Ellen Moran. Their article originally appeared in the American Evaluation Association's daily email,
aea365. It is reprinted here with permission.
We're Jennifer Rosinski, Senior Media Marketing Manager at UMass Medical School's Commonwealth
Medicine division and Ellen Moran, a contributing writer. Promoting your research, projects, and subject
matter knowledge through the media can enhance your professional reputation across and outside of your
field. This visibility may increase your chances of winning new grants or clients, or additional dissemination
possibilities.
But how do you do it, and do it well? We're both longtime newspaper journalists who receive "pitches" or
story suggestions of all kinds, and use that experience to get the word out about our researchers,
evaluators, and content matter experts.
Read More
EVENTS
 November 2016 Events  
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Human Research Protection Program (HRPP)
Upcoming Educational Opportunities
Clinical Research Professionals Group (CRPG) Meetings:
Tuesday, December 13, 2016
11:00 am - 12:00 pm
Hiatt Auditorium S1-608, UMMS, Worcester
Friday, January 13, 2017
9:00 - 10:00 am
Hiatt Auditorium S1-608
Wednesday, February 8, 2017
12:00 - 1:00 pm
Hiatt Auditorium S1-608
Monday, March 5, 2017
1:00 - 2:00 pm
Hiatt Auditorium S1-608
Thursday, April 13, 2017
2:00 - 3:00 pm
Hiatt Auditorium S1-608
Tuesday, May 16, 2017
1:00 - 2:00 pm
Hiatt Auditorium S1-608
Monday, June 11, 2017
3:00 - 4:00 pm
Hiatt Auditorium S1-608
Learn More
HIPAA and Research Series
Please join us for a series on HIPAA and research with joint presentations from the Privacy Officers, IRB,
an IT.
Sign-up for session
Wednesday, November 30, 2016
12:00 - 1:00 pm
Amphitheater I, S2-102, UMMS, Worcester
"HIPAA and Data Storage, Handling and Destruction"
Seal the Deal for your Medical Device: Alternative
Funding Streams
Johnson & Johnson Innovation, JLABS wants to introduce you to some of
the options when it comes to funding your device, in the hopes that you
meet your match and seal the deal.
December 1, 2016
10:00 am
M2D2, 110 Canal Street, 4th floor, Lowell, MA
Program Overview:
What are the options for an early-stage medical device company to secure funding for their innovation? Do
you know some of the routes and funding streams, including traditional venture capital, that might be a fit for
your company?
Register today!
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UMass Life Sciences Moment Fund
Call for Letters of Intent
The UMass Center for Clinical and Translational Science is pleased to
announce a funding call for the UMass Life Sciences Moment Fund (LSMF) 2016. The UMass LSMF
supports projects that are inter-campus in orientation and directed towards life sciences projects related to
clinical and translational research.
Deadline for letters of intent: November 21, 2016
Read More
UMCCTS Pilot Project Program (PPP)
Call for Letters of Intent
The UMass Center for Clinical and Translational Science (UMCCTS) is
announcing the next funding round for the Pilot Project Program (PPP) 2016.
The intent of the funding is to speed up the rate of progress to move a research
project, clinical finding or other discovery into a broader network of activities, while maximizing the breadth
of transdisciplinary skills applied to the research question. We are particularly interested in proposals
which feature a clinical scientist working with a basic scientist, proposals with an emphasis on community-
based research, and proposals that support the career development of new investigators.
Deadline for letters of intent: November 21, 2016
Read More
UMMS Office of Global Health
 Pilot Project Program (OGH-PPP)
Call for Letters of Intent
The UMMS Office of Global Health announces the 2017 OGH-Pilot
Project Program request for proposals. The key goal of OGH-PPP funding is to catalyze the
development of translational research projects that provide a firm scientific basis for clinical practice and
public health policy in global settings. The intent of the OGH-PPP is to promote and prioritize for funding
projects that are innovative, interdisciplinary, evidence-based, capitalize on University of Massachusetts
Medical School (UMMS) programmatic strengths, and that have the best potential for future growth and
external funding.
Deadline for letters of intent: November 21, 2016
Read More
Small Conference Grants are Available!
The UMass Center for Clinical and Translational Science offers Small Conference
Grants (SCG) designed to leverage the convening capacity of the UMCCTS to
create new, multidisciplinary teams to address a pressing health need. The
conference can be a symposium, educational program, seminar, workshop or any
other organized and formal meeting. The goal of the SCG is to facilitate
networking opportunities between faculty that focus on clinical and
translational research.
If you have an idea for an event that a SCG could help fund, visit the UMCCTS website for more information
and RFA or contact Nate Hafer, PhD, Director of Operations, UMCCTS.
The Doris Duke Charitable Foundation
2017 Clinical Scientist Development Award Competition
Pre-proposals are being sought from junior physician-scientist faculty
conducting clinical research in any disease area. Competitive applicants are
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expected to have research experience and publication records consistent with
the rank of assistant professor.
The Clinical Scientist Development Award does not require institutional nomination. This competition
employs a two-stage process. Pre-proposals will be reviewed and up to 50 applicants will be invited to
submit a full proposal.
Pre-proposals Due: November 29, 2016
Learn More
Antimicrobial Resistance Diagnostic Challenge
Can you help create a diagnostic tool for health care providers to
better identify resistant bacterial infections?
The main purpose of the Antimicrobial Resistance Diagnostic Challenge is to
incentivize the development of one or more rapid, point-of-care in vitro diagnostic
tests that would be of significant clinical and public health utility to combat the development and spread of
antibiotic resistant bacteria or diagnostic tests that distinguish between bacterial and viral infections.
$20 million in prize awards
Letters of Intent due December 23, 2016
Learn More
HHMI Launches New Program for Early-Career Scientists
Hanna H. Gray Fellows Program Seeks to Enhance Diversity in
Life Sciences
The Howard Hughes Medical Institute (HHMI) announces a new program to recruit and retain early-career
scientists who are from gender, racial, ethnic, and other groups underrepresented in the life sciences,
including those from disadvantaged backgrounds.
Deadline for applications: February 15, 2017
Learn More
Repurposing Research to Improve Patient Outcomes in
Huntington's Disease
This request for proposals is soliciting research proposals to identify repurposed
treatments for Huntington's Disease. We are interested in generic or proprietary
drugs, devices and nutriceuticals that could be repurposed to reduce the symptoms, progression and/or
incidence of Huntington's Disease, to thereby improve patient outcomes and reduce the suffering caused
by this disease.
Deadline for Project Proposal Summary Submissions: February 28, 2017
Read More
CTSA Collaborative Innovation Awards Update
Notice of Modifications to PAR-15-172 "Collaborative Innovation Award, Clinical and Translational Science
Award (CTSA) Program (U01)" to Expand the List of High Priority Translational Research Opportunities on
or after March 9, 2017
The purpose of this Notice is to make modifications for PAR-15-172 and subsequent due dates, and
expand the list of high priority translational research opportunites to novel clinical trials of drugs that target
shared molecular etiologies underlying multiple diseases.
4
UMass Center for Clinical and Translational Science Newsletter, Vol. 2016 [2016], Iss. 11, Art. 1
https://escholarship.umassmed.edu/umccts_news/vol2016/iss11/1
DOI: 10.13028/a74h-3213
Learn More
NIH Peer Review Online Briefings for Fellowship and R01 Grant Applicants and
Basic Research Grant Applicants and Reviewers (NOT-OD-16-152)
 
The purpose of this Notice is to inform NIH grant applicants, their mentors, and reviewers about three online
video briefings the NIH Center for Scientific Review (CSR) will host in November and December 2016.
CSR is the portal for NIH grant applications and their review for scientific and technical merit.
 
Each Briefing Will Have a Different Focus
 
Fellowship and R01 grant applicants:  The first two briefings will provide these applicants key information
that could help them better navigate the NIH peer review process.
 
Basic research grant applicants and reviewers:  The third briefing will reaffirm NIH's commitment to basic
research and help applicants and reviewers better do their part in proposing and reviewing basic research.
Briefing Title Date
8 Ways to Successfully Navigate NIH Peer Review and Get an R01 Grant December 1, 2016
NIH Peer Review Briefing for Basic Research Applicants and Reviewers December 2, 2016
 
All of the briefings will run from 2:00 to about 3:00 p.m. Eastern Time, including a 30 minute Q&A period.
Read More
Please remember to cite the CTSA Grant # UL1-TR001453 in all supported journal
publications.
The UMass Center for Clinical and Translational Science (UMCCTS) was founded in 2006 to enhance clinical and
translational research across the five University of Massachusetts campuses and our clinical partner, UMass Memorial
Health Care. With the receipt of an NIH Clinical and Translational Science Award (CTSA) in 2010, and its successful
renewal in 2015, the UMCCTS joined a network of 62 NIH-funded centers collaborating to transform the conduct of clinical
and translational research across the U.S. Other key partners include our patients and communities, foundations,
biotechnology and pharmaceutical companies, and members of the venture capital and philanthropic communities.
We encourage you to browse through our website to learn more about how the UMCCTS catalyzes clinical and
translational research through education and training, pilot funding programs, cores, services and collaboration.
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